结果显示，AP-CML 和 BP-CML 患者 5 年总生存率（OS）可观，TKI 治疗效果良好。该研究为临床治疗提供重要参考。 儿童慢性髓性白血病（Chronic Myeloid Leukemia，CML）是一种在儿童时期较为罕见的疾病，它就像隐藏在孩子身体里的 “小恶魔”，悄无声息地破坏着身体的 ...

ABL1 digital PCR can reliably quantify stable deep molecular remission of chronic myeloid leukemia (CML), which will help to ...

ABL1 digital PCR can reliably quantify stable deep molecular remission of chronic myeloid leukemia (CML), which will help to determine for which patients chronic drug treatment could potentially be ...

Emma Butler, 32, from Dublin, is encouraging anyone with symptoms - especially women - to not ignore them and go to their GP ...

ABL1 digital PCR can reliably quantify stable deep molecular remission of chronic myeloid leukemia (CML), which will help to determine for which patients chronic drug treatment could potentially be ...

17, 2024 — According to new research, 80% of patients with previously untreated or relapsed/refractory advanced-phase chronic myeloid leukemia (CML) -- including both accelerated or myeloid ...

Kolibaba, KS, Druker BJ. Current Status of Treatment for Chronic Myelogenous Leukemia. MedGenMed 2(2), 2000 [formerly published in Medscape Hematology-Oncology eJournal 3(2), 2000]. Available at ...

Various clinical trials have evaluated the clinical value of an initial dose intensification of imatinib in CML-CP patients (an overview of the most important response rates is given in Table 1).

2025 – Researchers have found that the clinical application of BCR::ABL1 digital PCR can reliably quantify stable deep molecular remission of chronic myeloid leukemia (CML), which will help to ...

Cash, cash equivalents and marketable securities of $358 million, expected to provide runway into 2028 ...